- Home
- BENF vs NDRA Comparison
BENF vs NDRA Comparison
Compare BENF & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BENF
- NDRA
- Stock Information
- Founded
- BENF 2003
- NDRA 2007
- Country
- BENF United States
- NDRA United States
- Employees
- BENF N/A
- NDRA N/A
- Industry
- BENF Blank Checks
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BENF Finance
- NDRA Health Care
- Exchange
- BENF Nasdaq
- NDRA Nasdaq
- Market Cap
- BENF 2.6M
- NDRA 3.1M
- IPO Year
- BENF N/A
- NDRA 2017
- Fundamental
- Price
- BENF $0.51
- NDRA $4.16
- Analyst Decision
- BENF
- NDRA Strong Buy
- Analyst Count
- BENF 0
- NDRA 1
- Target Price
- BENF N/A
- NDRA $46.00
- AVG Volume (30 Days)
- BENF 7.5M
- NDRA 28.4K
- Earning Date
- BENF 09-19-2025
- NDRA 08-14-2025
- Dividend Yield
- BENF N/A
- NDRA N/A
- EPS Growth
- BENF N/A
- NDRA N/A
- EPS
- BENF N/A
- NDRA N/A
- Revenue
- BENF N/A
- NDRA N/A
- Revenue This Year
- BENF N/A
- NDRA N/A
- Revenue Next Year
- BENF $53.55
- NDRA N/A
- P/E Ratio
- BENF N/A
- NDRA N/A
- Revenue Growth
- BENF N/A
- NDRA N/A
- 52 Week Low
- BENF $0.22
- NDRA $2.90
- 52 Week High
- BENF $2.36
- NDRA $22.68
- Technical
- Relative Strength Index (RSI)
- BENF 71.51
- NDRA 40.57
- Support Level
- BENF $0.36
- NDRA $4.06
- Resistance Level
- BENF $0.42
- NDRA $4.69
- Average True Range (ATR)
- BENF 0.08
- NDRA 0.30
- MACD
- BENF 0.01
- NDRA 0.03
- Stochastic Oscillator
- BENF 59.65
- NDRA 22.54
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.